NASDAQ · NVNO
enVVeno Medical Corporation
$7.02+$0.28 (+4.08%)
enVVeno Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.37% below the high.
Loading market information…
OTC · SCRCQ · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ScripsAmerica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ScripsAmerica, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ScripsAmerica, Inc. specializes in crafting and selling non-sterile creams for topical and transdermal pain management. Beyond its product offerings, the company provides medication dispensing support to individual doctors and supplies administrative and billing solutions for independent pharmacies. It also functions as a distributor, supplying pharmaceutical goods to standalone drugstores and other healthcare providers. Established in 2008, ScripsAmerica is based in Clifton, New Jersey. The company initially filed for Chapter 11 bankruptcy protection on September 7, 2016, before its reorganization case was subsequently changed to Chapter 7 liquidation on February 8, 2017.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$7.02+$0.28 (+4.08%)
enVVeno Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.37% below the high.
$0.00$0.00 (0.0%)
Banyan Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.18$0.00 (0.0%)
Ampio Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.55% below the high.
$0.00$0.00 (0.0%)
VMS Rehab Systems, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.02$0.00 (0.0%)
Easy Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+500.0%)
Scorpius Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.4% below the high.
$0.00$0.00 (0.0%)
Todos Medical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
That Marketing Solution, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
